Stay updated on Apitegromab in Later-Onset SMA Clinical Trial
Sign up to get notified when there's something new on the Apitegromab in Later-Onset SMA Clinical Trial page.

Latest updates to the Apitegromab in Later-Onset SMA Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page has been updated to reflect a new completion status and a future date of March 7, 2025, while removing a previous status indicating that it was not actively recruiting and a date of May 13, 2024.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check43 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check51 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check65 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check72 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this aspect.SummaryDifference1.0%
Stay in the know with updates to Apitegromab in Later-Onset SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apitegromab in Later-Onset SMA Clinical Trial page.